Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
Hoofdauteurs: | John R. Lydeard, Michelle I. Lin, Huanying Gary Ge, Amanda Halfond, Shu Wang, Mark B. Jones, Julia Etchin, Gabriella Angelini, Juliana Xavier-Ferrucio, Jessica Lisle, Kienan Salvadore, Yonina Keschner, Hannah Mager, Julian Scherer, Jianxin Hu, Siddhartha Mukherjee, Tirtha Chakraborty |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Elsevier
2023-12-01
|
Reeks: | Molecular Therapy: Methods & Clinical Development |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S2329050123002061 |
Gelijkaardige items
-
P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
door: J. Xavier-Ferrucio, et al.
Gepubliceerd in: (2022-06-01) -
260 Novel CLL-1-directed CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of acute myeloid leukemia
door: Mariana Silva, et al.
Gepubliceerd in: (2023-11-01) -
Role of myeloid-derived suppressor cells in hormone-dependent cancers
door: Siddhartha Mukherjee, et al.
Gepubliceerd in: (2021-03-01) -
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
door: Vyas, P, et al.
Gepubliceerd in: (2015) -
Sptlc1 is essential for myeloid differentiation and hematopoietic homeostasis
door: Velayoudame Parthibane, et al.
Gepubliceerd in: (2019-11-01)